Balance Sheet Diaceutics PLC

Stocks

DXRX

GB00BJQTGV64

Business Support Services

Market Closed - London S.E. 11:35:18 2026-09-03 EDT			5-day change	1st Jan Change
146.50 ^GBX	0.00%		+2.09%	+14.45%

08-20	Diaceutics and Precision Cancer Consortium Launch Ngs Concordance Study to Advance Precision Oncology and Support Informed Biomarker Testing	CI
07-29	Diaceutics PLC Reports Revenue Results for the Half Year Ended 30 June 2026	CI

5cd2e1d9cc920dd0780afe.dXcYu3xB3zKiRsuxhXNT0UF-xlyoBk6oFZbAzTEC3ro.LwF2jigv63jxCIL69x07nQNOlizLK3nNY9P5lHBJncwREE30NSvyVesu_w

Published financial data: DIACEUTICS PLC

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (GBP)	2022 (GBP)	2023 (GBP)	2024 (GBP)	2025 (GBP)
Revenues	13.94M	19.5M	23.7M	32.16M	38.44M
Total Revenues	13.94M	19.5M	23.7M	32.16M	38.44M
Cost of Goods Sold, Total	3.21M	2.76M	3.99M	3.89M	6.96M
Gross Profit	10.73M	16.74M	19.71M	28.27M	31.48M
Selling General & Admin Expenses, Total	10.38M	16.28M	22.78M	30.74M	31.69M
Other Operating Expenses	-195K	-114K	-60K	-17K	-255K
Other Operating Expenses, Total	10.18M	16.17M	22.72M	30.72M	31.44M
Operating Income	550K	575K	-3.02M	-2.46M	43K
Interest Expense, Total	-88K	-120K	-66K	-54K	-58K
Interest And Investment Income	-	111K	646K	601K	317K
Net Interest Expenses	-88K	-9K	580K	547K	259K
Other Non Operating Income (Expenses)	-	-2K	-	-	-
EBT, Excl. Unusual Items	462K	564K	-2.44M	-1.91M	302K
Restructuring Charges	-	-	-	-	-
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	462K	564K	-2.44M	-1.91M	302K
Income Tax Expense	-99K	-160K	-692K	-205K	205K
Earnings From Continuing Operations	561K	724K	-1.75M	-1.7M	97K
Net Income to Company	561K	724K	-1.75M	-1.7M	97K
Net Income - (IS)	561K	724K	-1.75M	-1.7M	97K
Net Income to Common Incl Extra Items	561K	724K	-1.75M	-1.7M	97K
Net Income to Common Excl. Extra Items	561K	724K	-1.75M	-1.7M	97K
Per Share Items
Net EPS - Basic	0.01	0.01	-0.02	-0.02	0
Basic EPS - Continuing Operations	0.01	0.01	-0.02	-0.02	0
Basic Weighted Average Shares Outstanding	83.94M	84.15M	84.23M	84.45M	84.58M
Net EPS - Diluted	0.01	0.01	-0.02	-0.02	0
Diluted EPS - Continuing Operations	0.01	0.01	-0.02	-0.02	0
Diluted Weighted Average Shares Outstanding	84.94M	86.09M	84.23M	84.45M	85.13M
Normalized Basic EPS	0	0	-0.02	-0.01	0
Normalized Diluted EPS	0	0	-0.02	-0.01	0
Payout Ratio	-	-	-	-	-
Supplemental Items
EBITDA	1.52M	2.08M	102K	552K	4.08M
EBITA	1.43M	1.93M	-59K	385K	3.92M
EBIT	550K	575K	-3.02M	-2.46M	43K
EBITDAR	-	-	-	-	-
Effective Tax Rate - (Ratio)	-21.43	-28.37	28.38	10.74	67.88
Current Domestic Taxes	-535K	-670K	314K	-191K	-
Current Foreign Taxes	83K	336K	798K	989K	1.3M
Total Current Taxes	-452K	-334K	1.11M	798K	1.3M
Total Deferred Taxes	353K	174K	-1.8M	-1M	-1.1M
Normalized Net Income	289K	352K	-1.52M	-1.19M	189K
Interest on Long-Term Debt	88K	122K	66K	54K	58K
Supplemental Operating Expense Items
Marketing Expenses	-	-	-	-	-
General and Administrative Expenses	10.38M	16.28M	22.78M	30.74M	31.69M
Research And Development Expense From Footnotes	-	-	-	-	-
Net Rental Expense, Total	-	-	-	-	-
Imputed Operating Lease Interest Expense	-	-	-	-	-
Imputed Operating Lease Depreciation	-	-	-	-	-
Stock-Based Comp., G&A Exp. (Total)	428K	-	-	-	-
Stock-Based Comp., Other (Total)	-	621K	538K	1.26M	1.13M
Total Stock-Based Compensation	428K	621K	538K	1.26M	1.13M

Fiscal Period: December	2021 (GBP)	2022 (GBP)	2023 (GBP)	2024 (GBP)	2025 (GBP)
Assets
Cash And Equivalents	19.68M	19.84M	16.67M	12.74M	7.34M
Total Cash And Short Term Investments	19.68M	19.84M	16.67M	12.74M	7.34M
Accounts Receivable, Total	7M	8.37M	9.83M	14.81M	19.71M
Other Receivables	2.92M	2.05M	300K	889K	1.14M
Total Receivables	9.92M	10.43M	10.13M	15.7M	20.85M
Prepaid Expenses	430K	628K	1.24M	1.08M	1.05M
Other Current Assets, Total	37K	-	-	-	119K
Total Current Assets	30.06M	30.9M	28.04M	29.53M	29.36M
Gross Property Plant And Equipment	2.42M	2.69M	2.8M	2.9M	3.34M
Accumulated Depreciation	-291K	-598K	-900K	-1.22M	-1.68M
Net Property Plant And Equipment	2.13M	2.09M	1.9M	1.68M	1.66M
Long-term Investments	-	-	-	-	-
Other Intangibles, Total	12.6M	15.04M	15.26M	15.41M	16.08M
Deferred Tax Assets Long-Term	1K	46K	1.14M	2M	2.9M
Deferred Charges Long-Term	216K	178K	-	-	-
Total Assets	45.01M	48.26M	46.34M	48.62M	50.01M
Liabilities
Accounts Payable, Total	513K	759K	1.06M	1.22M	1.54M
Accrued Expenses, Total	1.64M	2M	2.26M	5.05M	6.23M
Short-term Borrowings	130K	-	-	-	-
Current Portion of Long-Term Debt	-	-	-	-	-
Current Portion of Leases	146K	124K	146K	153K	270K
Current Income Taxes Payable	-	423K	471K	467K	27K
Unearned Revenue Current, Total	208K	411K	408K	337K	395K
Other Current Liabilities	-	39K	38K	543K	91K
Total Current Liabilities	2.63M	3.75M	4.38M	7.76M	8.55M
Long-Term Debt	-	-	-	-	-
Long-Term Leases	1.28M	1.2M	1.06M	907K	882K
Unearned Revenue Non Current	-	-	-	-	-
Deferred Tax Liability Non Current	445K	706K	28K	-	-
Other Non Current Liabilities	-	79K	88K	91K	95K
Total Liabilities	4.36M	5.74M	5.56M	8.76M	9.53M
Common Stock, Total	168K	169K	169K	170K	170K
Additional Paid In Capital	36.86M	37.13M	37.13M	-	-
Retained Earnings	4.08M	5.34M	4.04M	40.62M	41.6M
Treasury Stock	-165K	-263K	-312K	-312K	-312K
Comprehensive Income and Other	-302K	138K	-240K	-626K	-980K
Total Common Equity	40.65M	42.51M	40.79M	39.86M	40.48M
Total Equity	40.65M	42.51M	40.79M	39.86M	40.48M
Total Liabilities And Equity	45.01M	48.26M	46.34M	48.62M	50.01M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	83.94M	84.26M	84.25M	84.52M	84.66M
ECS Total Common Shares Outstanding	83.94M	84.26M	84.25M	84.52M	84.66M
Book Value / Share	0.48	0.5	0.48	0.47	0.48
Tangible Book Value	28.04M	27.47M	25.52M	24.44M	24.4M
Tangible Book Value Per Share	0.33	0.33	0.3	0.29	0.29
Total Debt	1.56M	1.33M	1.2M	1.06M	1.15M
Net Debt	-18.11M	-18.51M	-15.46M	-11.68M	-6.19M
Debt Equivalent Oper. Leases	-	-	-	-	-
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	482K	619K	728K	828K	896K
Full Time Employees	133	151	184	199	205
Accumulated Allowance for Doubtful Accounts (Supple)	20K	-	-	-	-
Order Backlog	-	-	-	24.93M	38.92M

Fiscal Period: December	2021 (GBP)	2022 (GBP)	2023 (GBP)	2024 (GBP)	2025 (GBP)
Net Income	561K	724K	-1.75M	-1.7M	97K
Depreciation & Amortization - CF	134K	304K	314K	321K	457K
Amortization of Goodwill and Intangible Assets - (CF)	882K	1.35M	2.96M	2.84M	3.88M
Depreciation & Amortization, Total	1.02M	1.66M	3.27M	3.16M	4.33M
Amortization of Deferred Charges, Total - (CF)	783K	1.35M	1.5M	1.47M	1.48M
(Gain) Loss From Sale Of Asset	-	-	3K	-	-
Asset Writedown & Restructuring Costs	-	-	-	87K	-
Stock-Based Compensation (CF)	373K	536K	445K	1.02M	915K
Other Operating Activities, Total	-505K	1.16M	-624K	-2.08M	-1.14M
Change In Accounts Receivable	-1.5M	-1.59M	-2.16M	-4.68M	-5.15M
Change In Accounts Payable	-159K	1.27M	618K	3.37M	643K
Cash from Operations	570K	5.1M	1.31M	651K	1.18M
Capital Expenditure	-565K	-186K	-125K	-100K	-71K
Sale (Purchase) of Intangible assets	-5.04M	-4.68M	-4.73M	-4.53M	-6.38M
Other Investing Activities, Total	-	111K	646K	601K	317K
Cash from Investing	-5.6M	-4.76M	-4.21M	-4.03M	-6.13M
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	-	-	-
Long-Term Debt Repaid, Total	-49K	-163K	-179K	-199K	-333K
Total Debt Repaid	-49K	-163K	-179K	-199K	-333K
Issuance of Common Stock	-	129K	-	136K	-
Repurchase of Common Stock	-165K	-98K	-49K	-	-
Common Dividends Paid	-	-	-	-	-
Common & Preferred Stock Dividends Paid	-	-	-	-	-
Other Financing Activities, Total	-56K	-59K	-11K	-1K	-
Cash from Financing	-270K	-191K	-239K	-64K	-333K
Foreign Exchange Rate Adjustments	-279K	20K	-37K	-479K	-115K
Net Change in Cash	-5.58M	166K	-3.17M	-3.92M	-5.4M
Supplemental Items
Cash Interest Paid	56K	59K	11K	1K	-
Cash Income Tax Paid (Refund)	325K	-1.39M	-690K	1.33M	1.02M
Levered Free Cash Flow	-5.55M	-355K	-1.18M	-2.35M	-4.08M
Unlevered Free Cash Flow	-5.49M	-280K	-1.14M	-2.31M	-4.05M
Change In Net Working Capital	2.46M	-602K	-291K	2.04M	4.56M
Net Debt Issued / Repaid	-49K	-163K	-179K	-199K	-333K

Fiscal Period: December	2021 (GBP)	2022 (GBP)	2023 (GBP)	2024 (GBP)	2025 (GBP)
Profitability
Return on Assets	0.78	0.77	-3.99	-3.23	0.05
Return on Total Capital	0.83	0.84	-4.4	-3.7	0.07
Return On Equity %	1.39	1.74	-4.19	-4.22	0.24
Return on Common Equity	1.39	1.74	-4.19	-4.22	0.24
Margin Analysis
Gross Profit Margin %	76.97	85.83	83.15	87.91	81.9
SG&A Margin	74.42	83.47	96.14	95.6	82.45
EBITDA Margin %	10.88	10.64	0.43	1.72	10.63
EBITA Margin %	10.27	9.89	-0.25	1.2	10.2
EBIT Margin %	3.94	2.95	-12.73	-7.63	0.11
Income From Continuing Operations Margin %	4.02	3.71	-7.37	-5.3	0.25
Net Income Margin %	4.02	3.71	-7.37	-5.3	0.25
Net Avail. For Common Margin %	4.02	3.71	-7.37	-5.3	0.25
Normalized Net Income Margin	2.07	1.81	-6.43	-3.71	0.49
Levered Free Cash Flow Margin	-39.79	-1.82	-4.98	-7.3	-10.62
Unlevered Free Cash Flow Margin	-39.39	-1.43	-4.81	-7.2	-10.52
Asset Turnover
Asset Turnover	0.31	0.42	0.5	0.68	0.78
Fixed Assets Turnover	11.78	9.24	11.88	17.98	23
Receivables Turnover (Average Receivables)	2.26	2.54	2.6	2.61	2.23
Short Term Liquidity
Current Ratio	11.41	8.23	6.4	3.8	3.43
Quick Ratio	11.24	8.07	6.11	3.66	3.3
Operating Cash Flow to Current Liabilities	0.22	1.36	0.3	0.08	0.14
Days Sales Outstanding (Average Receivables)	161.58	143.87	140.2	140.25	163.9
Average Days Payable Outstanding	55.64	84.02	83.37	107.41	72.23
Long Term Solvency
Total Debt/Equity	3.84	3.13	2.95	2.66	2.85
Total Debt / Total Capital	3.7	3.03	2.87	2.59	2.77
LT Debt/Equity	3.16	2.83	2.6	2.28	2.18
Long-Term Debt / Total Capital	3.04	2.75	2.52	2.22	2.12
Total Liabilities / Total Assets	9.69	11.9	11.99	18.02	19.05
EBIT / Interest Expense	6.25	4.79	-45.73	-45.46	0.74
EBITDA / Interest Expense	17.8	18.61	3.86	13.07	75.45
(EBITDA - Capex) / Interest Expense	11.38	17.06	1.97	11.22	74.22
Total Debt / EBITDA	1	0.6	4.73	1.5	0.26
Net Debt / EBITDA	-11.57	-8.29	-60.64	-16.55	-1.41
Total Debt / (EBITDA - Capex)	1.56	0.65	9.27	1.75	0.27
Net Debt / (EBITDA - Capex)	-18.1	-9.04	-118.94	-19.28	-1.44
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	9.82	39.88	21.51	35.69	19.53
Gross Profit, 1 Yr. Growth %	13.41	36.86	17.71	43.46	11.35
EBITDA, 1 Yr. Growth %	256.94	36.85	-95.09	441.18	640.04
EBITA, 1 Yr. Growth %	265.31	34.71	-103.06	-752.54	917.92
EBIT, 1 Yr. Growth %	-303.7	4.55	-624.87	-18.65	-101.75
Earnings From Cont. Operations, 1 Yr. Growth %	113.31	29.06	-341.16	-2.46	-105.7
Net Income, 1 Yr. Growth %	113.31	29.06	-341.16	-2.46	-105.7
Normalized Net Income, 1 Yr. Growth %	-257.14	22.08	-532.27	-21.74	-115.83
Diluted EPS Before Extra, 1 Yr. Growth %	94.55	27.29	-346.77	-2.56	-105.44
Accounts Receivable, 1 Yr. Growth %	31.05	19.59	17.41	50.67	33.02
Net Property, Plant and Equip., 1 Yr. Growth %	794.54	-1.74	-9.23	-11.64	-0.83
Total Assets, 1 Yr. Growth %	3.43	7.2	-3.96	4.91	2.85
Tangible Book Value, 1 Yr. Growth %	-10.4	-2.05	-7.08	-4.23	-0.18
Common Equity, 1 Yr. Growth %	1.02	4.59	-4.06	-2.28	1.56
Cash From Operations, 1 Yr. Growth %	125.3	794.04	-74.27	-50.34	81.11
Capital Expenditures, 1 Yr. Growth %	312.41	-67.08	-32.8	-20	-29
Levered Free Cash Flow, 1 Yr. Growth %	-13.22	-93.61	232.89	98.91	73.81
Unlevered Free Cash Flow, 1 Yr. Growth %	-13.65	-94.91	307.42	103.15	74.78
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	1.85	23.94	30.37	28.41	27.35
Gross Profit, 2 Yr. CAGR %	2.02	33.01	26.93	29.95	26.39
EBITDA, 2 Yr. CAGR %	-18.63	121.01	-74.07	-48.44	532.84
EBITA, 2 Yr. CAGR %	-20.28	121.83	-79.7	-55.33	715.01
EBIT, 2 Yr. CAGR %	-48.68	45.93	134.25	106.63	-88.06
Earnings From Cont. Operations, 2 Yr. CAGR %	18.72	65.92	76.42	53.37	-76.43
Net Income, 2 Yr. CAGR %	18.72	65.92	76.42	53.37	-76.43
Normalized Net Income, 2 Yr. CAGR %	-49.96	38.51	129.72	83.93	-64.8
Diluted EPS Before Extra, 2 Yr. CAGR %	3.17	57.37	77.24	55.07	-76.97
Accounts Receivable, 2 Yr. CAGR %	6.84	25.19	18.5	33.01	41.57
Net Property, Plant and Equip., 2 Yr. CAGR %	300.09	196.48	-5.56	-10.44	-6.39
Total Assets, 2 Yr. CAGR %	41.85	5.3	1.47	0.38	3.88
Tangible Book Value, 2 Yr. CAGR %	22.28	-6.32	-4.6	-5.67	-2.23
Common Equity, 2 Yr. CAGR %	42.1	2.79	0.17	-3.18	-0.38
Cash From Operations, 2 Yr. CAGR %	-4.88	348.8	51.66	-64.26	-5.17
Capital Expenditures, 2 Yr. CAGR %	138.89	16.52	-52.96	-26.68	-24.63
Levered Free Cash Flow, 2 Yr. CAGR %	38.62	-76.45	-53.87	157.32	85.94
Unlevered Free Cash Flow, 2 Yr. CAGR %	41.38	-79.03	-54.46	187.69	88.43
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	10.36	13.21	23.13	32.12	25.37
Gross Profit, 3 Yr. CAGR %	16.42	17.53	27.7	32.21	23.43
EBITDA, 3 Yr. CAGR %	-0.14	-3.23	-37.86	-28.61	25.31
EBITA, 3 Yr. CAGR %	-1.24	-5.04	-46.81	-35.46	26.65
EBIT, 3 Yr. CAGR %	-26.86	-34.94	123.59	64.65	-57.87
Earnings From Cont. Operations, 3 Yr. CAGR %	-3.91	22.07	87.94	44.79	-48.83
Net Income, 3 Yr. CAGR %	-3.91	22.07	87.94	44.79	-48.83
Normalized Net Income, 3 Yr. CAGR %	-24.7	-32.64	102.41	60.44	-18.8
Diluted EPS Before Extra, 3 Yr. CAGR %	-22.33	10.65	82.83	45.19	-49.23
Accounts Receivable, 3 Yr. CAGR %	19.71	10.93	22.54	28.38	33.01
Net Property, Plant and Equip., 3 Yr. CAGR %	206.43	150.56	99.82	-7.63	-7.35
Total Assets, 3 Yr. CAGR %	79.29	29.21	2.12	2.6	1.2
Tangible Book Value, 3 Yr. CAGR %	132.51	13.57	-6.57	-4.48	-3.87
Common Equity, 3 Yr. CAGR %	149.11	28.3	0.45	-0.65	-1.62
Cash From Operations, 3 Yr. CAGR %	-15.78	100.74	73.05	4.53	-38.61
Capital Expenditures, 3 Yr. CAGR %	109.77	23.39	-3.01	-43.85	-27.46
Levered Free Cash Flow, 3 Yr. CAGR %	25.63	-50.29	-43.05	-24.92	125.78
Unlevered Free Cash Flow, 3 Yr. CAGR %	28.16	-53.31	-43.63	-25.03	143.66
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	24.89	21.49	17.97	19.06	24.8
Gross Profit, 5 Yr. CAGR %	32.23	27.92	23.71	22.35	27.17
EBITDA, 5 Yr. CAGR %	7.64	17.48	-41.77	-24.77	57.24
EBITA, 5 Yr. CAGR %	6.5	16.21	-47.55	-29.77	58.48
EBIT, 5 Yr. CAGR %	-9.02	-8.6	16.51	3.29	-30.75
Earnings From Cont. Operations, 5 Yr. CAGR %	-5.57	1.77	22.52	33.74	-18.09
Net Income, 5 Yr. CAGR %	-5.57	1.77	22.52	33.74	-18.09
Normalized Net Income, 5 Yr. CAGR %	-10.06	-6.4	17.64	0.67	0.54
Diluted EPS Before Extra, 5 Yr. CAGR %	-82.65	-81.02	8.04	26.64	-20.18
Accounts Receivable, 5 Yr. CAGR %	29.46	38.01	19.22	19.28	29.83
Net Property, Plant and Equip., 5 Yr. CAGR %	157.33	111.54	91.37	66.03	47.54
Total Assets, 5 Yr. CAGR %	67.24	54.44	42.78	16.8	2.82
Tangible Book Value, 5 Yr. CAGR %	95.01	76.66	62.81	5.44	-4.86
Common Equity, 5 Yr. CAGR %	109.29	86.63	73.03	14.64	0.12
Cash From Operations, 5 Yr. CAGR %	-3.3	27.14	6.56	0.66	36.04
Capital Expenditures, 5 Yr. CAGR %	109.73	31.15	15.35	0.2	-12.32
Levered Free Cash Flow, 5 Yr. CAGR %	76.04	-20.25	-15.85	-4.05	-8.58
Unlevered Free Cash Flow, 5 Yr. CAGR %	70.33	-24.88	-15.27	-3.37	-8.66